Newly acquired Oridion Microstream exhaled carbon dioxide measurement technology dovetails with Covidien’s pulse oximetry and other patient monitoring products.
Medtronic Minimally Invasive Therapies will gain capnography carbon dioxide measuring technology for the first time through its acquisition of patient monitoring device maker Oridion Systems Ltd. for $300 million under a definitive agreement announced April 5.
Oridion identifies itself as the global leader in capnography – the continuous monitoring of carbon dioxide in exhaled breath –...
The pulsed-field ablation market is surging, with the UK NHS opening doors and FDA updates for major players. Medtech Insight spoke with Steven Mickelsen, founder of Farapulse (the first clinically approved PFA system), about the sector's growth and his new venture, Field Medical.
Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.
An interactive look at medtech and diagnostics deals made during June 2025. Data courtesy of Biomedtracker.
Thena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.
